The present invention relates to an inserter for an intrauterine system, comprising a handle (3) having a longitudinal opening (8) at its first end, said opening (8) having a longitudinal axis parallel to the longitudinal axis of the inserter, a first end (8a) and a second end (8b), a movable slider (5) arranged in said longitudinal opening (8) and having a first end (5a) and a second end (5b), a plunger (2) attached to the handle (3) and having a longitudinal axis, and an insertion tube (6) having a first end, a second end and a longitudinal axis essentially parallel to the longitudinal axis of the plunger (2), the insertion tube (6) being, along said longitudinal axis, movably arranged around the plunger (2). The invention is characterised in that it further comprises a flange (4) arranged on the insertion tube (6) at its first end, and means for locking the slider (5) into a position showing the correct insertion depth for the intrauterine system, said means being adjustable with respect to the opening (8) of the handle.

In one embodiment, the present invention provides an intrauterine device (IUD) comprising an oval shape, wherein the device comprises a core of magnetic material, an inert material or copper coating the core, wherein the coating comprises a pharmaceutical agent, copper or a combination thereof. Another embodiment provides a method to suppress estrus in a subject comprising inserting an intrauterine device (IUD) comprising an oval shape, wherein the device comprises a core of magnetic material and an inert material or copper coating the core.

In one embodiment, the present invention provides an intrauterine device (IUD) comprising an oval shape, wherein the device comprises a core of magnetic material, an inert material or copper coating the core, wherein the coating comprises a pharmaceutical agent, copper or a combination thereof. Another embodiment provides a method to suppress estrus in a subject comprising inserting an intrauterine device (IUD) comprising an oval shape, wherein the device comprises a core of magnetic material and an inert material or copper coating the core.

Described herein is a device, for insertion into a lumen of a human, the device comprising at least one cannabinoid. Optionally, the device is configured for insertion into a uterus of a female patient. The device is configured to gradually release the cannabinoid to the device's surroundings over time. Additionally, described herein are methods for treatment of a disease comprising administering to a patient in need thereof, a pharmaceutically acceptable amount of a cannabinoid via an intrauterine route. Optionally, the disease is endometrial cancer, uterine sarcoma, cervical cancer, Abnormal Pap Smears, Abnormal Uterine Bleeding, Endometriosis, Fibroids, Menopause, Ovarian Masses, Pelvic Pain, Polycystic Ovarian Syndrome, Sexually Transmitted Disease, Urinary Tract Infections, Vaginitis or ovarian cancer. Optionally, the disease is Lynch syndrome.

Described herein is a device, for insertion into a lumen of a human, the device comprising at least one cannabinoid. Optionally, the device is configured for insertion into a uterus of a female patient. The device is configured to gradually release the cannabinoid to the device's surroundings over time. Additionally, described herein are methods for treatment of a disease comprising administering to a patient in need thereof, a pharmaceutically acceptable amount of a cannabinoid via an intrauterine route. Optionally, the disease is endometrial cancer, uterine sarcoma, cervical cancer, Abnormal Pap Smears, Abnormal Uterine Bleeding, Endometriosis, Fibroids, Menopause, Ovarian Masses, Pelvic Pain, Polycystic Ovarian Syndrome, Sexually Transmitted Disease, Urinary Tract Infections, Vaginitis or ovarian cancer. Optionally, the disease is Lynch syndrome.

An insertion device for an IUD. The insertion device comprises an introducer having an elongate hollow body and a first end and a second end, the hollow body defining an elongate passageway extending from the first end to the second end and defining openings at the first end and the second end, and a pusher provided or configured to be provided inside the elongate passageway such that the pusher is movable through or along the passageway. The passageway is sized to accommodate an IUD such that the IUD is slidable along the passageway. Further, the second end of the introducer that abuts the fundus of the uterus in use is configured to have an increased surface area relative to prior art devices so as to reduce the risk of injury, including perforation of the uterus.

A pelvic prolapse treatment belt includes a main structural member having an inner and outer side for wrapping around a wearer including up to their hips. The main structural member includes a plurality of through-hole regions positioned to be located on respective sides of a wearer's spine. A compression pad is attached to the main structural member that has a wider top and a narrower bottom. The compression pad is configured for placing over a pelvic cavity of the wearer to provide support. A first and a second strap are attached to the narrower bottom and have a length sufficient for extending over the wearer's buttocks. The straps are sized for being pulled through the through-hole and have a distal end with an attachment feature for attaching to the outer side of the main structural member.

An intrauterine device (IUD) is insertable into a uterus of a mare to suppress estrus and estrus-related behaviors in mares. The IUD may take the form of a weighted ball or sphere that is biocompatible and includes a string attached to the weighted ball for ease of removal by pulling down on the string.

Disclosed are devices and methods for loading an intrauterine device (IUD) with a thread or suture engaged therewith into an insertion device. The devices and methods are suitable for use with an automated knot tying system.

The present invention relates to an implant, an ovarian cancer screening test kit comprising same, and an ovarian cancer screening test method using same, thereof wherein the implant is mounted in the uterine cavity so that the working channel maintain a path from the cervix to the fallopian tube for a predetermined period. According to the implant for screening test of ovarian cancer, the screening test kit comprising same, and the ovarian cancer screening test method using same of the present invention, the implant mounted in the uterus can be used to execute the screening test, can simply carry out periodically repeated screening tests to improve the convenience and minimize discomfort for the patient, and can allow both cystoscopy and biopsy.